These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2571199)

  • 21. Characterization of thrombospondin as a substrate for factor XIII transglutaminase.
    Lynch GW; Slayter HS; Miller BE; McDonagh J
    J Biol Chem; 1987 Feb; 262(4):1772-8. PubMed ID: 2879842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue transglutaminase and factor XIII in cartilage and bone remodeling.
    Aeschlimann D; Mosher D; Paulsson M
    Semin Thromb Hemost; 1996; 22(5):437-43. PubMed ID: 8989828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1 inhibitor cross-linking by tissue transglutaminase.
    Hauert J; Patston PA; Schapira M
    J Biol Chem; 2000 May; 275(19):14558-62. PubMed ID: 10799541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII.
    Bakker EN; Pistea A; Spaan JA; Rolf T; de Vries CJ; van Rooijen N; Candi E; VanBavel E
    Circ Res; 2006 Jul; 99(1):86-92. PubMed ID: 16741156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of factor XIIIa (active fibrin-stabilizing factor) in normal plasma.
    Nelson JC; Lerner RG
    Blood; 1978 Sep; 52(3):581-91. PubMed ID: 678674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of factor XIII with fibrin as substrate and cofactor.
    Hornyak TJ; Shafer JA
    Biochemistry; 1992 Jan; 31(2):423-9. PubMed ID: 1731900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets.
    Muszbek L; Haramura G; Polgár J
    Thromb Haemost; 1995 Apr; 73(4):702-5. PubMed ID: 7495082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of Fas-mediated apoptosis by plasma transglutaminase factor XIII that catalyzes fetal-specific cross-link of the Fas molecule.
    Kikuchi H; Kuribayashi F; Imajoh-Ohmi S
    Biochem Biophys Res Commun; 2014 Jan; 443(1):13-7. PubMed ID: 24216108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding and degradation of blood coagulation factor XIII by cultured fibroblasts.
    Barry EL; Mosher DF
    J Biol Chem; 1990 Jun; 265(16):9302-7. PubMed ID: 1971626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.